For the most common type of lung cancer in Americans, deaths are falling faster than new cases, a new study reports, suggesting — but not proving — that new therapies targeting genetic mutations are having an outsize effect on survival.
Mortality rates for patients with non-small cell lung cancer, which accounts for three-quarters of cancers originating in the lung, declined for men by…